Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
PCTL Stock Summary
Top 10 Correlated ETFs
PCTL
In the News

PCT LTD Announces New Financial Officer Appointment
LITTLE RIVER, S.C.--(BUSINESS WIRE)---- $pctl--PCT LTD (OTC:PINK “PCTL”) announced today that Arthur E. Abraham has been appointed Chief Financial Officer, effective May 17, 2021. Abraham will succeed Sheldon Smith, J.D., CPA, whose new role will be overseeing the compliance of PCT LTD's SEC filings and contract law. Abraham, 66, served as chief financial officer for various private and public organizations, as well as regional and corporate controller for manufacturing and distribution giants such as Ha

PCT LTD Announces Fiscal 2020 Results
LITTLE RIVER, S.C.--(BUSINESS WIRE)---- $PCTL--PCT LTD (OTC Pink: “PCTL”), reported financial results for the fiscal year ended December 31, 2020. 2020 Key Financial Highlights: Revenues for the year ended December 31, 2020 increased 255% to $2.5 million, as compared to $708 thousand in fiscal 2019. The revenue increase in 2020 was due to the increased volume of fluids sold during the COVID-19 pandemic, the sale of fluid-producing equipment, licensing revenue from EPA sub-registrations, and placing equip

PCT LTD Discusses 2021 Revenue Potential with The Stock Day Podcast
Phoenix, Arizona--(Newsfile Corp. - January 11, 2021) - The Stock Day Podcast welcomed PCT LTD (OTC Pink: PCTL) ("the Company"), a company that focuses its business on acquiring, developing and providing sustainable, environmentally safe disinfecting, cleaning and tracking technologies. CEO of the Company, Gary Grieco, joined Stock Day host, Everett Jolly. Jolly began the interview by asking about the Company's revenue potential for 2021. "In 2020, a massive percentage of revenues came from the...

PCT LTD (PCTL) Has Received an Additional $150K Conventional Convertible Funding from RB Capital Partners, Inc.
LITTLE RIVER, S.C.--(BUSINESS WIRE)---- $PCTL--PCT Ltd. (OTC Pink:PCTL) announces that PCTL and RB Capital Partners, Inc. have executed and received an additional $150,000 conventional, convertible loan with 5% annual interest and a $0.10/share fixed conversion rate. PCTL has earmarked a large portion of these monies for the build and completion of 4 Annihilyzer® Infection Control Systems for the Healthcare Industry and the completion of 3 pieces of the Company's Legacy equipment. With regard to the Comp
PCTL Financial details
PCTL Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2021-12-31
Metric | History | 2017-12-31 | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 |
---|---|---|---|---|---|---|
Revenue per share | 0 | 0.01 | 0 | 0 | 0 | |
Net income per share | -0.07 | -0.07 | -0.16 | -0.02 | 0.01 | |
Operating cash flow per share | -0.04 | -0.02 | 0 | 0 | 0 | |
Free cash flow per share | -0.04 | -0.02 | 0 | 0 | 0 | |
Cash per share | 0 | 0 | 0 | 0 | 0 | |
Book value per share | 0.08 | 0.04 | -0.05 | -0.02 | 0 | |
Tangible book value per share | -0.03 | -0.05 | -0.07 | -0.02 | -0.01 | |
Share holders equity per share | 0.08 | 0.04 | -0.05 | -0.02 | 0 | |
Interest debt per share | 0.03 | 0.05 | 0.02 | 0.01 | 0 | |
Market cap | 21.69M | 6.96M | 1.25M | 13.4M | 19.07M | |
Enterprise value | 22.81M | 8.86M | 3.67M | 16.18M | 21.2M | |
P/E ratio | -7.97 | -2.19 | -0.04 | -0.99 | 4.27 | |
Price to sales ratio | 176.17 | 26.16 | 1.77 | 5.32 | 14.88 | |
POCF ratio | -15.13 | -8.32 | -1.57 | -16.13 | -12.64 | |
PFCF ratio | -12.64 | -6.55 | -1.55 | -13.48 | -9.64 | |
P/B Ratio | 6.58 | 4.08 | -0.13 | -1.25 | -9.4 | |
PTB ratio | 6.58 | 4.08 | -0.13 | -1.25 | -9.4 | |
EV to sales | 185.31 | 33.31 | 5.18 | 6.42 | 16.55 | |
Enterprise value over EBITDA | -9.71 | -3.36 | -2.99 | -15.45 | -10.21 | |
EV to operating cash flow | -15.92 | -10.59 | -4.59 | -19.48 | -14.05 | |
EV to free cash flow | -13.3 | -8.34 | -4.55 | -16.28 | -10.72 | |
Earnings yield | -0.13 | -0.46 | -23.56 | -1.01 | 0.23 | |
Free cash flow yield | -0.08 | -0.15 | -0.64 | -0.07 | -0.1 | |
Debt to equity | 0.44 | 1.84 | -1.44 | -1.43 | -3.1 | |
Debt to assets | 0.31 | 0.65 | 3.27 | 3.32 | 1.48 | |
Net debt to EBITDA | -0.48 | -0.72 | -1.97 | -2.66 | -1.03 | |
Current ratio | 0.03 | 0.15 | 0.02 | 0.05 | 0.07 | |
Interest coverage | -27.94 | -12.88 | -0.82 | -1.01 | -5.27 | |
Income quality | 0.53 | 0.26 | 0.05 | 0.1 | -1.53 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 14.18 | 9.43 | 2.71 | 0.99 | 2.5 | |
Research and developement to revenue | 2.56 | 0.05 | 0.01 | 0.02 | 0.03 | |
Intangibles to total assets | 0.91 | 0.84 | 0.85 | 0.73 | 0.73 | |
Capex to operating cash flow | 0.2 | 0.27 | 0.01 | 0.2 | 0.31 | |
Capex to revenue | -2.29 | -0.85 | -0.01 | -0.06 | -0.37 | |
Capex to depreciation | -0.97 | -0.67 | -0.02 | -0.46 | -1.13 | |
Stock based compensation to revenue | 3.49 | 0 | 0 | 0 | 0.08 | |
Graham number | 0.36 | 0.25 | 0.43 | 0.09 | 0.02 | |
ROIC | -0.49 | -0.59 | -0.76 | -0.56 | -2.85 | |
Return on tangible assets | -6.34 | -4.04 | -44.02 | -10.93 | 3.87 | |
Graham Net | -0.04 | -0.07 | -0.07 | -0.02 | -0.01 | |
Working capital | -1.42M | -1.61M | -14.07M | -14.48M | -4.47M | |
Tangible asset value | -1.03M | -2.35M | -13.62M | -14.13M | -5.13M | |
Net current asset value | -1.42M | -2.86M | -14.07M | -14.62M | -5.97M | |
Invested capital | 0.34 | 1.12 | -0.25 | -0.27 | -1.11 | |
Average receivables | 8.33K | 30.89K | 80.53K | 230.72K | 222.77K | |
Average payables | 93.38K | 242.6K | 332.91K | 294.1K | 172.93K | |
Average inventory | 26.62K | 8.82K | 3.55K | 3.09K | 21.57K | |
Days sales outstanding | 37.47 | 67.4 | 57.66 | 50.63 | 27.36 | |
Days payables outstanding | 1.25K | 1.74K | 933.74 | 95.2 | 164.02 | |
Days of inventory on hand | 97.91 | 35.32 | 0 | 2.16 | 83.17 | |
Receivables turnover | 9.74 | 5.42 | 6.33 | 7.21 | 13.34 | |
Payables turnover | 0.29 | 0.21 | 0.39 | 3.83 | 2.23 | |
Inventory turnover | 3.73 | 10.34 | 0 | 169.14 | 4.39 | |
ROE | -0.83 | -1.87 | 2.98 | 1.26 | -2.2 | |
Capex per share | -0.01 | -0.01 | 0 | 0 | 0 |
Quarterly Fundamentals Overview
Last date of statement is 2022-09-30 for Q3
Metric | History | 2021-09-30 | 2021-12-31 | 2022-03-31 | 2022-06-30 | 2022-09-30 |
---|---|---|---|---|---|---|
Revenue per share | 0 | 0 | 0 | 0 | 0 | |
Net income per share | 0 | 0 | 0 | 0 | 0 | |
Operating cash flow per share | 0 | 0 | 0 | 0 | 0 | |
Free cash flow per share | 0 | 0 | 0 | 0 | 0 | |
Cash per share | 0 | 0 | 0 | 0 | 0 | |
Book value per share | 0 | 0 | 0 | 0 | 0 | |
Tangible book value per share | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 | |
Share holders equity per share | 0 | 0 | 0 | 0 | 0 | |
Interest debt per share | 0 | 0 | 0 | 0 | 0 | |
Market cap | 9.2M | 19.25M | 13.14M | 6.76M | 5.97M | |
Enterprise value | 11.32M | 21.38M | 15.83M | 9.28M | 8.47M | |
P/E ratio | -15.73 | -2.08 | 2.22 | 1.48 | -2.48 | |
Price to sales ratio | 25.09 | 386.66 | 43.74 | 23.79 | 20.63 | |
POCF ratio | -12.48 | -83.94 | -58.63 | -19.46 | -369.99 | |
PFCF ratio | -12.04 | -28.73 | -24 | -15.88 | -365.57 | |
P/B Ratio | -4.53 | -9.49 | 5.32 | -5.85 | -3.65 | |
PTB ratio | -4.53 | -9.49 | 5.32 | -5.85 | -3.65 | |
EV to sales | 30.85 | 429.48 | 52.68 | 32.68 | 29.26 | |
Enterprise value over EBITDA | 165.75 | -10.47 | -36.74 | -18.51 | -32.81 | |
EV to operating cash flow | -15.36 | -93.24 | -70.62 | -26.72 | -524.85 | |
EV to free cash flow | -14.81 | -31.91 | -28.9 | -21.81 | -518.59 | |
Earnings yield | -0.02 | -0.12 | 0.11 | 0.17 | -0.1 | |
Free cash flow yield | -0.08 | -0.03 | -0.04 | -0.06 | 0 | |
Debt to equity | -3.06 | -3.1 | 2.37 | -4.64 | -3.48 | |
Debt to assets | 1.49 | 1.48 | 1.36 | 1.27 | 1.4 | |
Net debt to EBITDA | 30.99 | -1.04 | -6.24 | -5.03 | -9.68 | |
Current ratio | 0.1 | 0.07 | 0.03 | 0.03 | 0.02 | |
Interest coverage | -8.5 | -22.47 | -7.42 | -6.22 | -2.56 | |
Income quality | 5.04 | 0.1 | -0.48 | -1.38 | 0.03 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 2.81 | 12.49 | 2.38 | 2.61 | 1.91 | |
Research and developement to revenue | 0.04 | 0.18 | 0.01 | 0 | 0 | |
Intangibles to total assets | 0.76 | 0.73 | 0.7 | 0.7 | 0.71 | |
Capex to operating cash flow | 0.04 | 1.92 | 1.44 | 0.23 | 0.01 | |
Capex to revenue | -0.07 | -8.85 | -1.08 | -0.28 | 0 | |
Capex to depreciation | -0.24 | -5.39 | -3.04 | -0.57 | 0 | |
Stock based compensation to revenue | 0 | 0 | 0.03 | 0.08 | 0.06 | |
Graham number | 0 | 0.01 | 0.01 | 0.01 | 0.01 | |
ROIC | -0.24 | -0.56 | -0.43 | -0.75 | -0.14 | |
Return on tangible assets | -0.14 | -2 | 1.17 | 0.9 | -0.51 | |
Graham Net | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 | |
Working capital | -5.56M | -4.47M | -4.21M | -3.77M | -4.12M | |
Tangible asset value | -5.2M | -5.13M | -4.58M | -4.1M | -4.51M | |
Net current asset value | -5.62M | -5.97M | -5.7M | -5.25M | -5.59M | |
Invested capital | -1.16 | -1.11 | 1.1 | -2.19 | -1.55 | |
Average receivables | 217.76K | 129.58K | 90.52K | 91.28K | 61.12K | |
Average payables | 116.4K | 66.86K | 148.77K | 273.86K | 442.36K | |
Average inventory | 9.34K | 24.64K | 23.6K | 10.75K | 24.93K | |
Days sales outstanding | 40.04 | 173.59 | 25.47 | 30.89 | 7.68 | |
Days payables outstanding | 63.99 | -102.82 | 901.94 | 555.15 | 8K | |
Days of inventory on hand | 12.95 | -52.14 | 41.17 | 19.31 | 549.8 | |
Receivables turnover | 2.25 | 0.52 | 3.53 | 2.91 | 11.71 | |
Payables turnover | 1.41 | -0.88 | 0.1 | 0.16 | 0.01 | |
Inventory turnover | 6.95 | -1.73 | 2.19 | 4.66 | 0.16 | |
ROE | 0.07 | 1.14 | 0.6 | -0.99 | 0.37 | |
Capex per share | 0 | 0 | 0 | 0 | 0 |
PCTL Frequently Asked Questions
What is PCT Ltd stock symbol ?
PCT Ltd is a US stock , located in Little river of Sc and trading under the symbol PCTL
What is PCT Ltd stock quote today ?
PCT Ltd stock price is $0.0038 today.
Is PCT Ltd stock public?
Yes, PCT Ltd is a publicly traded company.